Table 1.
Clinicopathological characteristics according to the presence or not of T2D. pT, pathological staging of primary tumor according to AJCC; F, female; LN, lymphnodes; M, male; mut, mutant; MS, microsatellite; wt: wildtype.
| Characteristic | T2D | P a | |
|---|---|---|---|
| No | Yes | ||
| Age | |||
| < 65 | 75 | 20 | |
| ≥ 65 | 87 | 21 | 0.7764 |
| Gender | |||
| M | 73 | 25 | |
| F | 89 | 16 | 0.0692 |
| Body‐mass index | |||
| Normal (18.5–24.9) | 68 | 12 | |
| Overweight (25–29.9) | 83 | 22 | |
| Obese (≥ 30) | 11 | 7 | 0.0714 |
| Grading | |||
| G1/G2 | 21 | 8 | |
| G3 | 141 | 33 | 0.2856 |
| Side of primary tumor | |||
| Left | 59 | 14 | |
| Right | 103 | 27 | 0.7869 |
| pT b | |||
| pT1/pT2 | 30 | 7 | |
| pT3 | 68 | 15 | |
| pT4 | 47 | 18 | 0.3345 |
| LN involvement b | |||
| 0 | 50 | 3 | |
| 1–3 | 62 | 14 | |
| > 3 | 33 | 19 | 0.0004 |
| RAS status | |||
| KRAS mut‐NRAS wt | 90 | 25 | |
| KRAS wt‐NRAS wt | 69 | 14 | 0.3963 |
| KRAS wt‐NRAS mut | 2 | 1 | |
| KRAS mut‐NRAS mut | 1 | 1 | |
| MS status | |||
| Stable | 146 | 37 | |
| Unstable | 5 | 1 | |
| Unknown | 11 | 3 | 0.9706 |
a
P at chi‐square test.
b
The row sum does not correspond to the total number of patients because some of them (22) did not receive surgical removal of primary tumor.